San Francisco, CA, United States of America

Nicholas M Santiago

This inventor holds 1 USPTO granted patent. Top assignee: Telik, Inc.. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nicholas M Santiago. Retrieved from https://idiyas.com/inventor/nicholas-m-santiago

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Nicholas M Santiago

Introduction

Nicholas M Santiago is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that enhance the efficacy of chemotherapeutic agents.

Latest Patents

Nicholas holds a patent for "Tripeptide and tetrapeptide thioethers." This patent encompasses pharmaceutical compositions that contain these compounds, detailing their pharmaceutical use and preparation. The compounds are designed to potentiate the cytotoxic effects of chemotherapeutic agents in tumor cells. They selectively exert toxicity in tumor cells, elevate the production of GM progenitors in bone marrow, stimulate the differentiation of bone marrow, mitigate the myelosuppressive effects of chemotherapeutic agents, and modulate hematopoiesis in bone marrow. He has 1 patent to his name.

Career Highlights

Nicholas is currently associated with Telik, Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on improving cancer treatment methodologies through the development of novel compounds.

Collaborations

Some of his notable coworkers include Natalia Aurrecoechea and Andrew B Kelson, who contribute to the collaborative efforts at Telik, Inc.

Conclusion

Nicholas M Santiago's work in developing tripeptide and tetrapeptide thioethers represents a significant advancement in cancer treatment. His innovative approach has the potential to improve the effectiveness of chemotherapy, making a meaningful impact in the field of oncology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…